December saw a change of the weather, but that did not stop a few hardy souls from the Medical Team at local business Actelion Pharmaceuticals UK Ltd from volunteering with Brentford FC Community Sports Trust at the Brentford Boating Arch facility.
The day was split between clearing-up the public facing surrounds of the boating arch, including weeding and clearing litter from the pathways and riverbanks. In two hours of work, the team of seven collected sixteen bags of rubbish with the most bizarre item collected being a surgical boot.
After a hearty lunch in the renowned Griffin Pub, the team then embarked on an afternoon of team-building activity.
Starting at the Griffin Park Learning Zone, the team took on our Urban Orienteering course around the local neighbourhood.
Andrew Bell, Corporate Partnerships and Events Manager at Brentford FC Community Sports Trust said “We are looking for links with local businesses to raise awareness of the work that we do at the Community Sports Trust and in the long-term create new forms of income for the Trust either through partnerships of corporate days such as this.
The staff at Actelion are based in Chiswick and did not realise the reach of the Community Sports Trust, we are hoping to introduce them to more aspects of the work we do in the future.”
For more information about our Corporate Partnerships Programme and how your company can support the trust whilst we support you then please email Andrew Bell at Brentford FC Community Sports Trust.
About Actelion Pharmaceutical Ltd
Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Switzerland. Actelion focuses on the discovery, development and commercialisation of innovative treatments to serve high unmet medical needs.
The Actelion UK and Ireland office was established in 2001 with four employees in a small office in London. The office is still in London, but has expanded to over 40 employees and now occupies the entire 13th floor of the Chiswick Tower Building on Chiswick High Road.
With a specific focus on rare and orphan diseases, the passionate and dedicated team always make sure that the patient is at the heart of everything they do. The commitment to science as a means to serve unmet medical needs and the drive to continue to develop effective therapies within this domain is strong and inherent in all the activities undertaken by the company.